Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes

Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes

Aim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and laboratory parameters and comorbidities.Material and methods. A retrospective analysis of clinical outcomes was carried out in 1985 patients wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. Yu. Demidova, K. G. Lobanova, S. N. Perekhodov, M. B. Antsiferov, O. Sh. Oynotkinova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	type 2 diabetes sars-cov-2 covid-19 mortality
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2750
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus
by: K. G. Lobanova, et al.
Published: (2021-09-01)

New onset of type 1 and type 2 diabetes post-COVID-19 infection: a systematic review
by: Ahmed El-Naas, et al.
Published: (2025-12-01)

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
by: Fawaz Alzaid, et al.
Published: (2020-09-01)

Relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease: a narrative review
by: José Luis Muñoz-Carrillo, et al.
Published: (2025-05-01)

Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facility
by: Muhilvannan Somasundaram, et al.
Published: (2024-12-01)

Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an ecological study
by: Daniel Ernesto Noyola, et al.
Published: (2021-10-01)

Clinical & Labor Clinical & Laboratory markers as pr ers as predictors for se ors for severity and erity and mortality in COVID-19
by: Asma Ameen Ghareeb, et al.
Published: (2023-09-01)

Retrospective Analysis of the Characteristics of the Post-COVID Period in Patients with Type 2 Diabetes, Infected During Different Variant-Associated Periods of COVID-19
by: S. A. Altynbekova, et al.
Published: (2024-11-01)

The rise in incidence of pediatric type 2 diabetes during the COVID-19 pandemic and the virus as a potential causative factor
by: Andrew Kanouse, et al.
Published: (2025-04-01)

Could the ABO Blood Group Types be Associated with COVID-19 Mortality?
by: Sema Alacam, et al.
Published: (2021-09-01)

Mortality from Coronavirus (Covid) SARS-CoV-2 in Oncological Patients
by: Hoyos-Pulgarín, Julián Andrés, et al.
Published: (2025-04-01)

Clinical behavior of COVID-19 in a reference public hospital in Mexico City during SARS-CoV-2 epidemiological waves
by: Alejandro Hernández-Solis, et al.
Published: (2025-01-01)

Weight loss in subjects with type 2 diabetes before and after SARS- CoV2 infection - A retrospective observational study
by: Roxana Adriana Stoica, et al.
Published: (2024-10-01)

Unveiling risk factors for post-COVID-19 syndrome development in people with type 2 diabetes
by: Anton Matviichuk, et al.
Published: (2024-12-01)

Prognostic factors of COVID-19 severity and mortality in the Yucatecan ethnic of México contrast with other populations
by: Gilma Guadalupe Sánchez-Burgos, et al.
Published: (2023-04-01)

Longitudinal analysis of Covid-19 infection trends and in-hospital mortality across six pandemic waves in Tunisia
by: Manel Ben Fredj, et al.
Published: (2025-04-01)

Exploring the associations between gut microbiota composition and SARS-CoV-2 inactivated vaccine response in mice with type 2 diabetes mellitus
by: Long Liu, et al.
Published: (2024-09-01)

Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan
by: Tomohiro Saito, et al.
Published: (2025-01-01)

Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves
by: Sonia Tchakerian, et al.
Published: (2024-11-01)

All-cause and Cause-Specific Excess Deaths during the COVID-19 Pandemic
by: Margherita Pizzato, et al.
Published: (2025-05-01)

Characteristics of COVID-19 cases and factors associated with their mortality in Katsina State, Nigeria, April-July 2020
by: Suleiman Idris Ahmad, et al.
Published: (2021-10-01)

Mid- and long-term mortality risk factors after COVID-19 hospitalization: A retrospective observational study in Peru
by: Max Carlos Ramírez-Soto, et al.
Published: (2025-06-01)

Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England
by: Igbinosa EG, et al.
Published: (2025-07-01)

Efficacy of combined treatment of distal polyneuropathy in patients with type 2 diabetes mellitus and concomitant primaryhypothyroidism
by: Inessa Ivanovna Dubinina, et al.
Published: (2011-09-01)

Prevalence of mortality among covid-19 patients in Kurdistan Region and various parts of the world and the role of ecological and environmental factors in shaping SARS-CoV-2 virulence
by: Muayad A. Mahmud
Published: (2022-08-01)

Diabetes exacerbates SARS-CoV-2 replication through ineffective pulmonary interferon responses, delayed cell-mediated immunity, and disruption of leptin signaling
by: Côme J. Thieulent, et al.
Published: (2025-03-01)

Comparative Analysis of SARS-CoV-2 Antibodies in Diabetic and Non-Diabetic Healthcare Workers Post-Infection and Vaccination
by: Mariya Rouf Tramboo1*, et al.
Published: (2024-06-01)

Risk of celiac disease, type 1 diabetes, and thyroid disease autoimmunity during the SARS-CoV-2 pandemic in South of Sweden: insights from the TRIAD study
by: Alexander Lind, et al.
Published: (2025-12-01)

Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection
by: Raluca-Ileana Pătru, et al.
Published: (2025-03-01)

A review of mortality in type 2 diabetes mellitus
by: Nailya Sayfullaevna Asfandiyarova
Published: (2015-12-01)

The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
by: Drieda Zaçe, et al.
Published: (2025-01-01)

Clinical laboratory parameters in patients with COVID-19
by: Naivy Sánchez Vera, et al.
Published: (2021-06-01)

Does blood type have an effect on the course of COVID-19?
by: Mesut Tığlıoğlu, et al.
Published: (2022-06-01)

Clinical characteristics and outcomes in patients with diabetes mellitus affected by COVID-19: a retrospective cross-sectional study from a tertiary care center in Pakistan
by: Asma Ahmed, et al.
Published: (2025-06-01)

COVID-19 and non–COVID-19 pneumonia: a comparison
by: Chiara Di Mitri, et al.
Published: (2021-01-01)

Caracterización de pacientes con Covid-19 y Neumonía Adquirida en la Comunidad, en un hospital de alta complejidad, durante la pandemia de Covid-19
by: Kevin Muñetón-Ramírez
Published: (2025-02-01)

Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomisation analysisResearch in context
by: Fiona Bragg, et al.
Published: (2025-05-01)

Impact of Early Administration of Albumin on Mortality Among Severe COVID-19 Patients, China
by: Sha J, et al.
Published: (2025-03-01)

High immunity and low mortality after Omicron and mass event in Cameroon despite low vaccination
by: Yap Boum II, et al.
Published: (2024-11-01)

Racial and Ethnic Disparities in Type 2 Diabetes Complications and In-Hospital Mortality in the United States: A Retrospective Cohort Study
by: Lainy A. Burress, et al.
Published: (2025-02-01)